These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 9921347

  • 21. The role of IL-10 and IgG1 in the protection and granulomatous response in Schistosoma mansoni P24-immunized mice.
    Zouain CS, Gustavson S, Oliveira SC, Azevedo V, Alves JB, Goes AM.
    Vaccine; 2000 Dec 08; 19(9-10):1218-24. PubMed ID: 11137260
    [Abstract] [Full Text] [Related]

  • 22. The ability of fractionated sera from animals vaccinated with irradiated cercariae of Schistosoma mansoni to transfer immunity to mice.
    Jwo J, LoVerde PT.
    J Parasitol; 1989 Apr 08; 75(2):252-60. PubMed ID: 2466975
    [Abstract] [Full Text] [Related]

  • 23. Early development and progression of lymphocyte-stimulatory cross-reactive idiotypes expressed on antibodies to soluble egg antigens during Schistosoma mansoni infection of mice.
    Bosshardt SC, Nix NA, Colley DG.
    Eur J Immunol; 1996 Jan 08; 26(1):272-5. PubMed ID: 8566079
    [Abstract] [Full Text] [Related]

  • 24. DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection.
    Gonçalves de Assis NR, Batistoni de Morais S, Figueiredo BC, Ricci ND, de Almeida LA, da Silva Pinheiro C, Martins Vde P, Oliveira SC.
    PLoS One; 2015 Jan 08; 10(5):e0125075. PubMed ID: 25942636
    [Abstract] [Full Text] [Related]

  • 25. Immunization with PIII, a fraction of Schistosoma mansoni soluble adult worm antigenic preparation, affects nitric oxide production by murine spleen cells.
    de Oliveira DM, do Carmo SA, Silva-Teixeira DN, Goes AM.
    Mem Inst Oswaldo Cruz; 1998 Jan 08; 93 Suppl 1():175-80. PubMed ID: 9921344
    [Abstract] [Full Text] [Related]

  • 26. A purified 28,000 dalton protein from Schistosoma mansoni adult worms protects rats and mice against experimental schistosomiasis.
    Balloul JM, Grzych JM, Pierce RJ, Capron A.
    J Immunol; 1987 May 15; 138(10):3448-53. PubMed ID: 3106483
    [Abstract] [Full Text] [Related]

  • 27. Fasciola gigantica fatty acid binding protein (FABP) as a prophylactic agent against Schistosoma mansoni infection in CD1 mice.
    Rabia Aly I, Diab M, El-Amir AM, Hendawy M, Kadry S.
    Korean J Parasitol; 2012 Mar 15; 50(1):37-43. PubMed ID: 22451732
    [Abstract] [Full Text] [Related]

  • 28. Protective effect and granuloma down-modulation promoted by RP44 antigen a fructose 1,6 bisphosphate aldolase of Schistosoma mansoni.
    Marques HH, Zouain CS, Torres CB, Oliveira JS, Alves JB, Goes AM.
    Immunobiology; 2008 Mar 15; 213(5):437-46. PubMed ID: 18472052
    [Abstract] [Full Text] [Related]

  • 29. Schistosoma mansoni-New Zealand rabbit model: resistance induced by infection followed by active immunization with protective antigens.
    Tendler M, Almeida MS, Pinto RM, Noronha D, Katz N.
    J Parasitol; 1991 Feb 15; 77(1):138-41. PubMed ID: 1899450
    [Abstract] [Full Text] [Related]

  • 30. A multivalent chimeric vaccine composed of Schistosoma mansoni SmTSP-2 and Sm29 was able to induce protection against infection in mice.
    Pinheiro CS, Ribeiro AP, Cardoso FC, Martins VP, Figueiredo BC, Assis NR, Morais SB, Caliari MV, Loukas A, Oliveira SC.
    Parasite Immunol; 2014 Jul 15; 36(7):303-12. PubMed ID: 24749785
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Immunological characterization of a chimeric form of Schistosoma mansoni aquaporin in the murine model.
    Figueiredo BC, De Assis NR, De Morais SB, Martins VP, Ricci ND, Bicalho RM, Pinheiro Cda S, Oliveira SC.
    Parasitology; 2014 Sep 15; 141(10):1277-88. PubMed ID: 24786243
    [Abstract] [Full Text] [Related]

  • 33. Immunochemical purification and characterization of a 74.0-kDa Schistosoma mansoni antigen.
    Attallah AM, El Masry SA, Ismail H, Attia H, Abdel Aziz M, Shehatta AS, Tabll A, Soltan A, El Wassif A.
    J Parasitol; 1998 Apr 15; 84(2):301-6. PubMed ID: 9576502
    [Abstract] [Full Text] [Related]

  • 34. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.
    El Ridi R, Tallima H.
    Vaccine; 2009 Jan 29; 27(5):666-73. PubMed ID: 19056448
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Schistosome egg antigens, including the glycoprotein IPSE/alpha-1, trigger the development of regulatory B cells.
    Haeberlein S, Obieglo K, Ozir-Fazalalikhan A, Chayé MAM, Veninga H, van der Vlugt LEPM, Voskamp A, Boon L, den Haan JMM, Westerhof LB, Wilbers RHP, Schots A, Schramm G, Hokke CH, Smits HH.
    PLoS Pathog; 2017 Jul 29; 13(7):e1006539. PubMed ID: 28753651
    [Abstract] [Full Text] [Related]

  • 40. Immunization with rP22 induces protective immunity against Schistosoma mansoni: effects on granuloma down-modulation and cytokine production.
    Rezende CM, Silva MR, Santos IG, Silva GA, Gomes DA, Goes AM.
    Immunol Lett; 2011 Dec 30; 141(1):123-33. PubMed ID: 21945176
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.